Institute of Biomedical Technologies/CNR, National Research Council, Milan, Italy.
Hypertens Res. 2013 Mar;36(3):270-6. doi: 10.1038/hr.2012.175. Epub 2012 Oct 18.
The role of apolipoprotein E (apoE) polymorphisms in regulating blood pressure (BP) is still not clear. The aim of this study was to examine longitudinal changes in BP levels by apoE genotypes in a population-based prospective cohort of elderly subjects, and explore interactions with plasma lipids and uric acid. Subjects whose apoE genes had been genotyped at baseline (1408, representing 80.8% of all the elderly residents in Bambuì city, south-eastern Brazil; age range 60-95 years) were included in the analysis. Repeated BP measurements were obtained in four waves. Multi-level random-effects pattern-mixture models were used to evaluate the age-related BP trajectories, accounting for non-ignorable dropouts/deaths and handling heterogeneities as random parameter variations. Subjects with the ɛ4/4 genotype and high levels of low-density lipoprotein cholesterol had higher systolic BP levels at 60 years of age than those with the other genotypes (154.5 vs. 133.2 mm Hg, P=0.020), but this was not the case among the older subjects. Systolic BP increased more rapidly with age in the ɛ2 carriers, leading to significantly higher levels among the oldest. This relationship seemed to be modulated by uric acid levels, as it was present in the subjects with the ɛ2/3 genotype and high uric acid levels, and in those with the ɛ2/4 genotype and low or normal uric acid levels. The differences in systolic BP between the genotypes were age dependent, and the shift between the ɛ4 and ɛ2 alleles suggest that these alleles are involved in the different mechanisms leading to increased BP in middle-aged and elderly subjects.
载脂蛋白 E(apoE)多态性在调节血压(BP)中的作用尚不清楚。本研究旨在通过apoE 基因型检查老年人队列中血压水平的纵向变化,并探讨其与血浆脂质和尿酸的相互作用。在基线时(代表巴西东南部班比市所有老年居民的 80.8%,年龄范围为 60-95 岁;n=1408)对 apoE 基因进行基因分型的受试者被纳入分析。在四个波次中进行了重复的 BP 测量。多水平随机效应模式混合模型用于评估与年龄相关的 BP 轨迹,考虑到不可忽略的失访/死亡和处理异质性作为随机参数变化。与其他基因型相比,ɛ4/4 基因型和高水平低密度脂蛋白胆固醇的受试者在 60 岁时收缩压水平更高(154.5 与 133.2mmHg,P=0.020),但在较年长的受试者中并非如此。ɛ2 携带者的收缩压随年龄增长的速度更快,导致最年长的受试者的收缩压水平显著升高。这种关系似乎受到尿酸水平的调节,因为它存在于ɛ2/3 基因型和高尿酸水平的受试者以及ɛ2/4 基因型和低或正常尿酸水平的受试者中。基因型之间的收缩压差异与年龄有关,ɛ4 和 ɛ2 等位基因之间的转变表明这些等位基因参与了导致中年和老年受试者血压升高的不同机制。